• Vor Bio to Participate in Upcoming Investor Conferences

    Source: Nasdaq GlobeNewswire / 01 Apr 2024 08:00:00   America/New_York

    CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

    23rd Annual Needham Virtual Healthcare Conference
    Fireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET
    Location: Virtual

    Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing Summit
    Fireside Chat: Monday, April 29, 2024 at 9:30 am ET
    Location: Virtual

    About Vor Bio
    Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

    Contact:

    Media & Investors
    Sarah Spencer
    +1 857-242-6076
    sspencer@vorbio.com


    Primary Logo

Share on,